Franciscan Missionaries of Our Lady Health System | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

559,641 results for “Franciscan Missionaries of Our Lady Health System”

Cytovale's IntelliSep Diagnostic Reduces Sepsis Mortality by 39% in Large Real-World Study

Our Lady of the Lake Cancer Institute Launches Louisiana's First Allogeneic CAR-T Cell Therapy Clinical Trial

Protect Our Care Launches National "Sick of It! Fix Health Care Now" Campaign Across Nine States

Our Future Health Cohort Tops 1.9 Million Participants, Mapping Disease Patterns Across the UK

LSU and FMOL Health Award $1.6M to Seven Research Teams Targeting Louisiana's Critical Health Challenges

Genetic Variations in Serotonin Receptors Influence Psychedelic Drug Potency

UC Davis Health First in Western US to Use Novel Supira pVAD System in High-Risk Cardiac Procedures

ClearFlow's PleuraFlow System Reduces Cardiac Surgery Complications by 41% in Large Clinical Trial

Alzheimer's Clinical Trial Update: New Data on Tau-Targeting Drugs and More

Yale Leverages Alignment to Expand Access to Cutting-Edge Treatments Like Teplizumab

Page 1 of 4081